Clinical trial · Interventional
Surveillance Pelvic Examination Anxiety: Brief Coping Skills Intervention
Developing and Pilot Testing a Brief Intervention to Reduce Anxiety During Pelvic Examinations Among Female Cancer Survivors (Pelvic Examination and Anxiety Coping Skills for Empowerment: PEACE)
NCT05285306CI-TRIAL-00066358PEACEcompletedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to test the feasibility and acceptability of a brief coping skills training program addressing anxiety and pain related to surveillance pelvic examinations for female gynecologic cancer survivors.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Anxiety | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| PEACE Program | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- PEACE Program
- description
- 3 sessions of tailored coping skills related to pelvic examinations
- interventionNames
- Behavioral: PEACE Program
Primary outcomes (8)
- measure
- Intervention acceptability will be assessed using an adapted version of the Satisfaction with Therapy and Therapist Scale (STTS-R)
- timeFrame
- post pelvic examination (approximately 2-3 months after baseline)
- description
- The adapted STTS-R consists of 18 items that assess satisfaction with the therapist and the intervention on a 5-point Likert-type scale from 1 (strongly disagree) to 5 (strongly agree).
- measure
- Change in intervention acceptability will be assessed using an adapted version of the Satisfaction with Therapy and Therapist Scale (STTS-R)
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * female sex * diagnosis of stage I-IV cervical or endometrial cancer * 18 years of age or older * able to speak/read English * able to give informed consent * completed cancer treatments within 2-24 months prior to enrollment, and recommended to undergo surveillance pelvic examination at three month intervals * able to commit to three 45-60 minute visits within the study period * able to participate in the intervention via the telemedicine modality (e.g., phone or video) Exclusion Criteria: * unable to provide informed consent * major untreated or uncontrolled mental illness * hearing impairment that impedes telephone or video calls
References
Publications (0)
Data not yet available
No reference posted for this study.